ClinicalTrials.govpublic full text
Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia
hereditary hemorrhagic telangiectasia, genetic diseases and dysmorphic syndromes, hematologic disorders, rare disease, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803452
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.